Skip to main content

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Integración de datos del mundo real, de salud y de investigación para la mejora de los protocolos clínicos en la enfermedad falciforme y otras anemias raras

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , David Beneitez Pastor, Maria Cristina Díaz de Heredia Rubio, Adoración Blanco Alvarez, Anna Collado Gimbert
Funding agency: Instituto de Salud Carlos III
Funding: 152500
Reference: PI24/00477
Duration: 01/01/2025 - 31/12/2027

ERDERA: European Rare Disease Research Alliance

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Sara Isabel Reidel , Miguel Chillon Rodriguez, Esther García Pagès, Raquel Mosull del Campo, Raquel Mosull del Campo, Simon Schwartz Navarro, Agustín Arasanz Duque, Sandra Mancilla Zamora, Anna Collado Gimbert, Marc Miquel Moltó Abad, Ángela Menárguez López, Ángela Menárguez López, Ángela Menárguez López, Claire Diot
Funding agency: EUROPEAN COMMISSION
Funding: 771525
Reference: ERDERA_MAÑU_EC_HLTH2023-DISEASE-07-01/2023
Duration: 01/09/2024 - 31/08/2031

ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases)

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Sara Isabel Reidel , Núria Torquet i Luna, Raquel Mosull del Campo, Raquel Mosull del Campo, Alba María Albert Robledo, Claire Diot, Daiana Natali Lopez , Maximo Tartaglia
Funding agency: EUROPEAN COMMISSION
Funding: 1569581.5
Reference: EUROBLOODNET-ERN_MAÑU_EU4H2023
Duration: 01/10/2023 - 30/09/2027

HemaFAIR: Fostering F.A.I.R. Data and Standards in Rare Hematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Sara Isabel Reidel , Núria Torquet i Luna, Esther García Pagès
Funding agency: EUROPEAN COMMISSION
Funding: 221875
Reference: HEMAFAIR/EC/WIDERA-2023-ACCESS-02-01/2023/MAÑU
Duration: 01/06/2024 - 30/06/2027

Related news

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

Vall d'Hebron is one of the centers that coordinate this network, which so far has enabled the detection of high-risk genetic alterations and the provision of personalized treatments that have already achieved remission in cases with very few therapeutic alternatives.

The projects, selected under the 2026 Health Research and CaixaImpulse Health Innovation calls, address topics ranging from new therapies for childhood neurological disorders and Parkinson’s disease to the treatment of mitochondrial diseases and cancer.

Related professionals

Eugeni Bruguera Cortada

Eugeni Bruguera Cortada

Senior researcher
Psychiatry, Mental Health and Addictions
Read more
Alberto Alegre Lifshitz

Alberto Alegre Lifshitz

Research technician
Diabetes and Metabolism
Read more
Ariadna Miquel Clopés

Ariadna Miquel Clopés

Research technician
Childhood Cancer and Blood Disorders
Read more
Gemma Cervero Martínez

Gemma Cervero Martínez

Research assistant
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.